Prader-Willi syndrome in siblings, due to unbalanced translocation between chromosomes 15 and 22 F FERNANDEZ, C BERRY, AND D MUTTON High Wycombe General Hospital and South East Thames Regional Genetics Centre, Guy's Hospital, London SUMMARY In a family in which the father carried a balanced translocation between chromosomes 15 and 22 two of his children had Prader-Willi syndrome and an unbalanced chromosome complement, having lost the proximal bands from the long arm of chromosome 15. His four other surviving children were normal but carried a balanced translocation.
Case report
The proband, who was 5 years old at the time of writing, was admitted to the special care baby unit when 3 days old with extreme hypotonia and feeding difficulties. He had been born to a consanguineous Asian couple and was the product of an uneventful pregnancy that had progressed to term; he had been delivered vaginally. Birth weight was 2020 g, and he appeared otherwise normal apart from bilaterally undescended testes and a small scrotum. Tube feeding was necessary for two months. His development was delayed both physically and mentally: he walked at the age of 3½/2 and attended a special school for the educationally subnormal.
His next younger sibling had identical problems and was managed in the special care baby unit from the age of 5 days. He also was tube fed for two months. At over 1 year old he had a developmental age of 9 months and hypogonadism.
The family details are shown as a pedigree in Figure 1 . Only about half of all cases can be diagnosed from chromosomal analyses. The finding of normal chromosomes does not rule out the possibility of Prader-Willi syndrome. In our case a previously unreported chromosomal abnormality was present and hence helped the diagnosis in both the affected and the carrier siblings.
Cytogenetics
Early diagnosis and counselling helped the parents understand the need for dietary control in the affected children. The proband did not put on a large amount of weight and was just on the third weight percentile for his age. The parents' religious beliefs precluded preventing the birth of further affected children, but, clearly, genetic counselling of the siblings carrying the translocation will be important. The possibility of using equally effective but safer spectral areas than the conventional 420-490 nm (blue part of the spectrum), in the treatment of neonatal jaundice is currently being investigated. It has been shown that green light is more effective than white in reducing serum bilirubin concentrations in preterm neonates.
The purpose of the present study was to evaluate the efficacy of green versus blue light in reducing serum bilirubin in term and preterm neonates with hyperbilirubinaemia.
Patients and methods
Standard 20 watt sylvania F2OT12G (green) or F20T12B (blue) fluorescent tubes were mounted on to conventional phototherapy units with five tubes each to provide the light source. The emission spectra were estimated with a Baush-Lomb 250 monochromator. The radiance of the lamps was measured from 50 cm away with a research IL 700 radiometer. The integrated emission energy was 0-326 milliwatt for the green light and 0-261 milliwatt for the blue light. A total of 262 neonates with jaundice of unknown aetiology were included, overt haemolysis having been excluded. They were separated into two groups according to their gestational age; 200 were born at term (>37 weeks) and 62 before term (<37 weeks). They were then randomly allocated into two subgroups to receive either green or blue phototherapy (Table 1) . 
